
    
      This study is a pre-Market, prospective, multi-center, single arm trial. Subjects will be
      enrolled and followed through 5 Years (screen, implant procedure(including post-procedure
      assessment),30-Day, 6 Months, 9 Months-subjects implanted with fringe size, and annual
      assessments from 1-5 years).
    
  